Access to the latest Korean startup news and startup database for free

#Weekly Funding Overview
[March.23~ March.27]#FUNDING
| Company | Inudustry | Amount | Round | Investors |
|---|---|---|---|---|
| Miboo Heavy Industries | Shipbuilding / MRO | 12.2 billion | IBKS Innovation Material/Parts/Equipment New Tech Investment Fund No. 4 | |
| Minish Technology | Tooth Restoration Solution | 30 billion | VIG Partners | |
| J-Innts Bio | Bio | 18 billion | Series C | Yuhan Corporation |
| Anabatic Semi | BMS Semi | 15 billion | Series B | Smilegate Investment, Mirae Asset Venture Inv., JB Inv., IBK Bank, IM Investment Partners, Ecopro Partners |
| Labrador Labs | Software Supply Chain Security | 14.5 billion | Series B | Shinhan Venture Investment, DS Asset Mgmt, POSCO Tech Investment, Stonebridge Ventures, Korea Asset, TK Investment., Novosec Investment |
| Plaif | Dual-arm Robots | 13.9 billion | Series A | Partners Investment, Woori Venture Partners, Stick Ventures |
| Pion Electric | Next-gen Energy Solution | 13 billion | Series B | Doosan Investment, D3 Jubilee Partners, Samchully Asset Management / SKS PE |
| New Cancer Cure Bio | Cancer Therapeutics | 5 billion | Intervalue Partners, Dongyu Technology Investment, Astone Ventures, Kingo Investment Partners | |
| Mobilint | AI Semiconductor Design | 4 billion | Series C | Company K Partners |
| MBD | 3D Cell Culture Platform | 4 billion | ||
| LPHYSIO | Posture Mgmt Studio | 300 million | Star Asset Partners | |
| Kimute | Daily Beauty Solution | - | Heim Venture Investment | |
| Jocoding AX Partners | AI Redesign Solution | - | Primer | |
| Cellac Bio | Bio-Aesthetics | - | The Founders | |
| IRVIS | Industrial Vision AI | - | Y&Archer | |
| MTG | Material & Adhesive Solution | - | Kingo Spring | |
| Choice For Women | Women's Wellness Underwear | - | M&A | The Future |
| Frefins | Rental Conversion Fintech | - | Alantes Corporate Finance | |
| THE GRIMM ENTERTAINMENT | Webtoon Production | - | Grant | Scale-up TIPS |
#TREND ANALYSIS
Korea’s Startup Market Is Now Winner Takes All
South Korea’s startup investment market is on track to exceed KRW 1.5 trillion in the first quarter of 2026, surpassing the same period last year, according to statistical data from Startup Recipe. But beneath the headline figures, a more troubling picture is emerging: funding for early-stage companies is drying up, while capital piles into later-stage businesses with validated models — widening a divide that is pushing the so-called “valley of death” deeper than ever.
Quarterly investment opened at KRW 375 billion in January, surged to a quarterly peak of KRW 697.9 billion in February, and has held above the KRW 400 billion mark in March, sustaining an upward trajectory on the surface. Stage-by-stage data, however, tells a starkly different story.
The most alarming signal is the rapid contraction of seed and pre-Series A investment — the stages that sustain startups before they reach stable growth. Seed-stage deals, which accounted for 22% of total investment activity in January, slipped to 20% by March. More striking is the collapse of pre-Series A funding, which serves as a critical bridge for early-stage companies before they can access larger rounds. Its share plummeted from 15% in January to just 4% in February, recovering only modestly to around 5% in March — shrinking to roughly one-third of its January level within a single quarter. The data signals that the gateway between early-stage founding and the next round of financing has grown significantly narrower, leaving a growing number of founding teams exposed to acute funding shortfalls.
On the other end of the spectrum, growth-stage investment has expanded sharply. Mid-to-late stage deals — spanning Series B through pre-IPO rounds — represented just 5% of investment activity in January, before surging nearly fourfold to approximately 19% in February and holding at around 17% in March, cementing their place as a market mainstream.
The trend was underscored by a series of large-ticket transactions. In February, SmartScore closed a 110 billion KRW pre-IPO round — one of the quarter’s most significant deals. March saw Autonomous A2Z secure 40.5 billion KRW, further illustrating the concentration of substantial capital in a small number of late-stage companies.
The late-stage capital surge has been most pronounced in bio and deep tech. In biotech, Ellicigen led the way in January with a KRW 42 billion Series C raise, followed in March by Must Bio (KRW 35 billion, Series C), Minish Technology (KRW 30 billion), and Ticaros (KRW 20.8 billion, Series D). On the deep tech side, autonomous driving firm Autonomous A2Z’s 40.5 billion KRW pre-IPO raise and robotics solutions company Twinny’s KRW 20.4 billion Series C were confirmed in March, with a handful of technically advanced, late-stage companies absorbing a disproportionate share of total market capital.
The first quarter of 2026 has reinforced a winner-takes-all investment dynamic. Despite active early-stage activity — including batch recruiting by accelerators — the large sums required for genuine business growth flowed almost exclusively to companies at Series B and beyond. Series A investment share remained essentially flat, hovering between 8% and 9% throughout the quarter, while the pre-Series A funding cliff deepened further.
#MORE NEWS
- Korea Launches Startup for All to Discover 5,000 Entrepreneurs
- South Korea Opens K-Startup of the Year 2026 With $370K Grand Prize
- K-Beauty Platform Memebox Raises $10M from ASQ Fund